vs

Side-by-side financial comparison of DULUTH HOLDINGS INC. (DLTH) and HARROW, INC. (HROW). Click either name above to swap in a different company.

DULUTH HOLDINGS INC. is the larger business by last-quarter revenue ($114.9M vs $89.1M, roughly 1.3× HARROW, INC.). HARROW, INC. runs the higher net margin — 7.4% vs -8.8%, a 16.2% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs -9.6%). HARROW, INC. produced more free cash flow last quarter ($8.1M vs $-8.9M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs -31.6%).

Duluth Holdings Inc., which primarily sells goods through its Duluth Trading Company brand, is an American workwear and accessories company.

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

DLTH vs HROW — Head-to-Head

Bigger by revenue
DLTH
DLTH
1.3× larger
DLTH
$114.9M
$89.1M
HROW
Growing faster (revenue YoY)
HROW
HROW
+42.9% gap
HROW
33.3%
-9.6%
DLTH
Higher net margin
HROW
HROW
16.2% more per $
HROW
7.4%
-8.8%
DLTH
More free cash flow
HROW
HROW
$17.0M more FCF
HROW
$8.1M
$-8.9M
DLTH
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
-31.6%
DLTH

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
DLTH
DLTH
HROW
HROW
Revenue
$114.9M
$89.1M
Net Profit
$-10.1M
$6.6M
Gross Margin
53.8%
79.3%
Operating Margin
-7.7%
17.5%
Net Margin
-8.8%
7.4%
Revenue YoY
-9.6%
33.3%
Net Profit YoY
64.6%
-2.2%
EPS (diluted)
$-0.29
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DLTH
DLTH
HROW
HROW
Q4 25
$114.9M
$89.1M
Q3 25
$131.7M
$71.6M
Q2 25
$102.7M
$63.7M
Q1 25
$241.3M
$47.8M
Q4 24
$127.1M
$66.8M
Q3 24
$141.6M
$49.3M
Q2 24
$116.7M
$48.9M
Q1 24
$245.6M
$34.6M
Net Profit
DLTH
DLTH
HROW
HROW
Q4 25
$-10.1M
$6.6M
Q3 25
$1.3M
$1.0M
Q2 25
$-15.3M
$5.0M
Q1 25
$-5.6M
$-17.8M
Q4 24
$-28.2M
$6.8M
Q3 24
$-2.0M
$-4.2M
Q2 24
$-7.9M
$-6.5M
Q1 24
$6.4M
$-13.6M
Gross Margin
DLTH
DLTH
HROW
HROW
Q4 25
53.8%
79.3%
Q3 25
54.7%
75.3%
Q2 25
52.0%
74.5%
Q1 25
44.1%
67.5%
Q4 24
52.3%
78.8%
Q3 24
52.3%
75.6%
Q2 24
52.8%
74.4%
Q1 24
48.2%
69.5%
Operating Margin
DLTH
DLTH
HROW
HROW
Q4 25
-7.7%
17.5%
Q3 25
1.8%
20.6%
Q2 25
-12.0%
17.9%
Q1 25
-1.8%
-23.5%
Q4 24
-17.4%
19.3%
Q3 24
-1.1%
2.7%
Q2 24
-7.7%
3.1%
Q1 24
3.6%
-20.0%
Net Margin
DLTH
DLTH
HROW
HROW
Q4 25
-8.8%
7.4%
Q3 25
1.0%
1.4%
Q2 25
-14.9%
7.8%
Q1 25
-2.3%
-37.2%
Q4 24
-22.2%
10.1%
Q3 24
-1.4%
-8.6%
Q2 24
-6.7%
-13.2%
Q1 24
2.6%
-39.2%
EPS (diluted)
DLTH
DLTH
HROW
HROW
Q4 25
$-0.29
$0.20
Q3 25
$0.04
$0.03
Q2 25
$-0.45
$0.13
Q1 25
$-0.17
$-0.50
Q4 24
$-0.84
$0.19
Q3 24
$-0.06
$-0.12
Q2 24
$-0.24
$-0.18
Q1 24
$0.20
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DLTH
DLTH
HROW
HROW
Cash + ST InvestmentsLiquidity on hand
$8.2M
$72.9M
Total DebtLower is stronger
$250.0M
Stockholders' EquityBook value
$160.6M
$52.4M
Total Assets
$468.0M
$399.5M
Debt / EquityLower = less leverage
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DLTH
DLTH
HROW
HROW
Q4 25
$8.2M
$72.9M
Q3 25
$5.7M
$74.3M
Q2 25
$8.6M
$53.0M
Q1 25
$3.3M
$66.7M
Q4 24
$9.3M
$47.2M
Q3 24
$9.8M
$72.6M
Q2 24
$6.8M
$71.0M
Q1 24
$32.2M
$76.0M
Total Debt
DLTH
DLTH
HROW
HROW
Q4 25
$250.0M
Q3 25
$347.2M
Q2 25
$250.6M
Q1 25
$256.9M
Q4 24
$262.7M
Q3 24
$230.7M
Q2 24
$236.3M
Q1 24
$243.4M
Stockholders' Equity
DLTH
DLTH
HROW
HROW
Q4 25
$160.6M
$52.4M
Q3 25
$170.0M
$47.0M
Q2 25
$167.9M
$49.7M
Q1 25
$182.7M
$56.5M
Q4 24
$188.1M
$69.7M
Q3 24
$215.7M
$58.0M
Q2 24
$218.4M
$58.5M
Q1 24
$222.8M
$60.6M
Total Assets
DLTH
DLTH
HROW
HROW
Q4 25
$468.0M
$399.5M
Q3 25
$433.8M
$363.1M
Q2 25
$463.7M
$345.0M
Q1 25
$452.4M
$364.2M
Q4 24
$533.1M
$389.0M
Q3 24
$488.6M
$351.5M
Q2 24
$471.4M
$306.6M
Q1 24
$491.2M
$295.5M
Debt / Equity
DLTH
DLTH
HROW
HROW
Q4 25
4.77×
Q3 25
7.39×
Q2 25
5.05×
Q1 25
4.55×
Q4 24
3.77×
Q3 24
3.98×
Q2 24
4.04×
Q1 24
4.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DLTH
DLTH
HROW
HROW
Operating Cash FlowLast quarter
$-6.7M
$8.4M
Free Cash FlowOCF − Capex
$-8.9M
$8.1M
FCF MarginFCF / Revenue
-7.8%
9.1%
Capex IntensityCapex / Revenue
2.0%
0.4%
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters
$1.7M
$43.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DLTH
DLTH
HROW
HROW
Q4 25
$-6.7M
$8.4M
Q3 25
$32.0M
$16.6M
Q2 25
$-56.5M
$-803.0K
Q1 25
$41.2M
$19.7M
Q4 24
$-41.1M
$-17.8M
Q3 24
$16.6M
$3.0M
Q2 24
$-33.7M
$-2.7M
Q1 24
$69.7M
$-4.6M
Free Cash Flow
DLTH
DLTH
HROW
HROW
Q4 25
$-8.9M
$8.1M
Q3 25
$29.8M
$16.4M
Q2 25
$-57.8M
$-969.0K
Q1 25
$38.7M
$19.5M
Q4 24
$-43.7M
$-18.3M
Q3 24
$15.0M
$2.3M
Q2 24
$-35.2M
$-3.1M
Q1 24
$60.6M
$-4.7M
FCF Margin
DLTH
DLTH
HROW
HROW
Q4 25
-7.8%
9.1%
Q3 25
22.6%
22.9%
Q2 25
-56.3%
-1.5%
Q1 25
16.0%
40.8%
Q4 24
-34.4%
-27.4%
Q3 24
10.6%
4.8%
Q2 24
-30.2%
-6.3%
Q1 24
24.7%
-13.6%
Capex Intensity
DLTH
DLTH
HROW
HROW
Q4 25
2.0%
0.4%
Q3 25
1.7%
0.3%
Q2 25
1.3%
0.3%
Q1 25
1.0%
0.4%
Q4 24
2.1%
0.8%
Q3 24
1.2%
1.2%
Q2 24
1.3%
0.7%
Q1 24
3.7%
0.3%
Cash Conversion
DLTH
DLTH
HROW
HROW
Q4 25
1.27×
Q3 25
25.40×
16.26×
Q2 25
-0.16×
Q1 25
Q4 24
-2.62×
Q3 24
Q2 24
Q1 24
10.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DLTH
DLTH

Sales Channel Directly To Consumer$67.4M59%
Sales Channel Through Intermediary$47.4M41%

HROW
HROW

Segment breakdown not available.

Related Comparisons